Goldman Sachs Group Inc

Filing Details

13F-HR/A • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-16
Total Holdings
11,314
Total Value
470725650026
Accession Number
0000769993-25-000301
Form Type
13F-HR/A
CIK
0000886982
Manager Name
Goldman Sachs Group Inc
Data Enrichment
86% identified
9,763 identified1,551 unidentified

Holdings

11,314 positions
Manager:
SEC
Search and click to pin securities to the top
Page 250 of 253
New Found Gold Corp.
NFGC|64440N103
Shares:
14512(-79.9%)
Value:
$17.4M(-86.7%)
PLBY Group, Inc.
PLBY|72814P109
Shares:
15504(-82.8%)
Value:
$17.1M(-87.0%)
SeaStar Medical Holding Corp
ICU|81256L203
Shares:
10204(-0.7%)
Value:
$16.9M(-15.0%)
CUMULUS MEDIA INC
CMLS|231082801
Shares:
37820(+19.4%)
Value:
$16.7M(-21.3%)
92731L304
92731L304
Shares:
31567
Value:
$16.7M
G0705H111
G0705H111
Shares:
220004(+0.0%)
Value:
$16.5M(-63.4%)
Alpha Tau Medical Ltd.
DRTSW|M0740A116
Shares:
69409(+0.0%)
Value:
$16.5M(+13.1%)
ClearSign Technologies Corp
CLIR|185064102
Shares:
20493(-51.9%)
Value:
$15.4M(-75.0%)
N94209108
N94209108
Shares:
44891(-84.0%)
Value:
$14.7M(-89.5%)
60800C208
60800C208
Shares:
17099(+15.8%)
Value:
$14.7M(-26.8%)
98944F117
98944F117
Shares:
256875(+0.0%)
Value:
$14.2M(-47.3%)
Gogoro Inc.
GGR|G9491K105
Shares:
51724(-63.4%)
Value:
$14.0M(-80.2%)
BIODESIX INC
BDSX|09075X108
Shares:
22094(-81.3%)
Value:
$13.8M(-92.3%)
83425V104
DTC|83425V104
Shares:
79883(-37.9%)
Value:
$13.4M(-90.8%)
Cue Biopharma, Inc.
CUE|22978P106
Shares:
14401(-58.3%)
Value:
$13.1M(-65.1%)
GALECTIN THERAPEUTICS INC
GALT|363225202
Shares:
10699(-77.5%)
Value:
$13.1M(-78.7%)
G7606H116
G7606H116
Shares:
239874(+0.0%)
Value:
$12.7M(-64.7%)
Solidion Technology Inc.
STI|834212102
Shares:
101053(-3.5%)
Value:
$12.2M(-83.3%)
52328E113
52328E113
Shares:
200004(+0.0%)
Value:
$12.1M(-39.4%)
G1893D110
G1893D110
Shares:
309716(+0.0%)
Value:
$12.1M(-40.4%)